140 likes | 168 Views
Explore the clinical presentation and surgical evolution of a morbidly obese patient undergoing gastric bypass and vertical banded gastroplasty surgeries, with emphasis on post-operative outcomes and liver function.
E N D
Clinical Presentation Mr. W is a 50 y/o WM with morbid obesity He has failed multiple attempts to keep a lower weight with diets. He loses 20-50 lb and gains more weight later His comorbidities make his life very difficult. He is sedentary and smokes daily
Past History DM II HTN Hyperlipidemia OSA GERD Lumbalgia Knee pain No prior abdominal surgery EtOH occasionally wine 3-4 times a yr Smokes 1ppd (25 pk/yr) Denies illegal drugs No allergies
Physical Exam BP 155/94 HR 92 RR 22 Ht 70 in Wt 453 BMI 65 General: morbidly obese WM, NAD HEENT: anicteric sclerae, MMM Neck: supple, no JVD, no LAD Lungs: CTA B Heart: RRR Abdomen: morbidly obese, no HSM Extremities: 1+ edema LE Neuro: AAO x 3; no asterixis
Evolution After a careful pre-operatory evaluation, he is taken for a gastric bypass surgery His work up included: CBC, CMP, PT, PTT Abdominal ultrasound Echocardiogram Polysomnography
Surgery At the operatory time, cirrhosis is found incidentally The surgeon decides to do a vertical banded gastroplasty instead of the GBP Liver biopsy taken Post operatory uneventful
VERTICAL BANDED GASTROPLASTY Stomach stapling Restrictive surgery Plastic Band Small pouch Normal absorption Failure in 25-50% patients
Post Op Mr. W lost 100 lb during the first 6 months His DM, BP, lipids, back pain improved He then started to drink high caloric liquids Gained 60 lbs back GBP was then scheduled
Gastric Bypass Stomach is stapled Roux-en-Y Restrictive and malabsorptive Low incidence of hepatic complications More consistent weight loss
Evolution Weight became stable at 250 lbs Metabolic syndrome resolved Liver function remained normal Fibrosis decreased in f/u biopsy